Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

No link found between Coxsackie viruses and pemphigus.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

miRNAs could help diagnose and treat gouty arthritis.

Interleukin-6 may play a role in causing alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Certain foods and supplements can help treat skin diseases alongside medication.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

ILC1 cells contribute to hair loss in alopecia areata.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Certain drugs may cause vitiligo, so patients should be monitored.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

PCOS is linked to low-grade chronic inflammation.

Baricitinib is an effective treatment for severe alopecia areata.

Hair care practices and concerns about maintaining hairstyles can reduce how often African American women exercise.